Stakeholder List
Midwest CEPAC

PDF cover

Ovarian Cancer: Stakeholder List

ICER identified the organizations in this document as key stakeholders for its upcoming report on poly ADP-ribose polymerase (PARP) inhibitors for Ovarian Cancer. ICER will invite input from the following organizations, and welcomes suggestions from the broader community on additional organizations to add to this list. ICER often receives comments from individual patients and clinicians, and invites the public to submit recommendations for key stakeholders in these categories.


View All Materials on this Topic or Go Back to View More Materials